EUVIMEDEUVIMED entdecken
Crossref

Electrophysiological assessment of flicker fusion frequency as an early biomarker of Alzheimer's disease in Drosophila

Lily Rivas

Rutgers University Community Repository (Rutgers University) · 02.09.2026

DOI: 10.7282/t3-esjr-mc98 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rutgers University Community Repository (Rutgers University), erschienen am 02.09.2026. Verfasst von Lily Rivas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease is a progressive neurodegenerative disorder that is characterized by the accumulation of toxic amyloid beta plaques. This leads to neuronal communication disruptions, neuronal death, and cognitive decline that effects 7.5 million people aged 65 and older and is the sixth leading cause of death in the United States, and mortality rates have increased from 142%from 2000 to 2022. Without major breakthroughs, the number of Americans living with Alzheimer’s disease is projected to reach over 13 million by 2050. A key challenge with Alzheimer’s research is that symptomology only occurs once significant neurodegeneration has occurred. This means that we need to find novel ways of identifying this disorder early. Clinical evidence suggests that flicker fusion frequency (FFF) changes in Alzheimer’s disease patients earlier than other behavioral symptoms. FFF is the frequency at which flickering light is perceived as continuous, and is used to assess temporal vision processing, and visual symptoms have been documented in Alzheimer’s disease patients. However, these symptoms have been observed in later stages of Alzheimer’s disease and cognitive decline is already occurring. The overall mechanisms of these visual symptoms are not well understood, specifically the degradation of temporal cognitive processing. To address this gap, we adopted a well established Alzheimer's model of Drosophila using the Gal4-UAS system to drive expression of APP and/or Abeta, the pathological portion of APP, in either neurons or photoreceptors of Drosophila. We hypothesize that expression only in photoreceptors will be sufficient to cause changes to FFF that is seen in the pan- neuronal expression of APP and/or Abeta. To confirm the successful development of these flies, we will validate offspring with the negative geotaxis assay, the photosensitivity assay, and a learning and memory assay. Once this has been confirmed, we will then use an Extracellular Electrophysiology Recording System to measure electroretinograms within the eyes of these drosophila lines to assess levels of impairment to FFF. We will then also modulate the temperature of these genetic lines to modify the GAL4 expression to induce greater symptomology in the Drosophila. Following this study, we will further characterize the FFF mechanisms within the photoceptors and identify mechanisms to identify Alzheimer's well before learning and memory deficits occur.

Schlagwörter

Alzheimer's diseasecritical flicker frequencyDrosophila modelamyloid-betaAPP overexpressionphotoreceptorselectroretinogramearly biomarkersGAL4/UASgeotaxis

Zitieren

APA

Rivas, L. (2026). Electrophysiological assessment of flicker fusion frequency as an early biomarker of Alzheimer's disease in Drosophila. Rutgers University Community Repository (Rutgers University). https://doi.org/10.7282/t3-esjr-mc98

Vancouver

Rivas L. Electrophysiological assessment of flicker fusion frequency as an early biomarker of Alzheimer's disease in Drosophila. Rutgers University Community Repository (Rutgers University). 2026. doi:10.7282/t3-esjr-mc98

BibTeX
@article{Rivas2026,
  author = {Rivas, Lily},
  title = {Electrophysiological assessment of flicker fusion frequency as an early biomarker of Alzheimer's disease in Drosophila},
  journal = {Rutgers University Community Repository (Rutgers University)},
  year = {2026},
  doi = {10.7282/t3-esjr-mc98}
}
Kostenlos starten →